Evidence map›Paper›PMID 25143347›Full record

ArticleAmerican journal of physiology. Cell physiology2014

A highly potent agonist to protease-activated receptor-2 reveals apical activation of the airway epithelium resulting in Ca2+-regulated ion conductance.

Cara L Sherwood, Michael O Daines, Theodore J Price, Josef Vagner, Scott Boitano

Abstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Protease-activated receptor 2 activates airway apical membrane chloride permeability and increases ciliary beating.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cara L SherwoodArizona Respiratory Center, University of Arizona, Tucson, Arizona; The BIO5 Collaborative Research Institute, University of Arizona, Tucson, Arizona.
Michael O DainesArizona Respiratory Center, University of Arizona, Tucson, Arizona; Department of Pediatrics, Arizona Health Sciences Center, University of Arizona, Tucson, Arizona; The BIO5 Collaborative Research Institute, University of Arizona, Tucson, Arizona.
Theodore J PriceDepartment of Pharmacology, Arizona Health Sciences Center, University of Arizona, Tucson, Arizona; and The BIO5 Collaborative Research Institute, University of Arizona, Tucson, Arizona.
Josef VagnerThe BIO5 Collaborative Research Institute, University of Arizona, Tucson, Arizona.
Scott BoitanoArizona Respiratory Center, University of Arizona, Tucson, Arizona; Department of Physiology, Arizona Health Sciences Center, University of Arizona, Tucson, Arizona; The BIO5 Collaborative Research Institute, University of Arizona, Tucson, Arizona sboitano@email.arizona.edu.
University of Arizona · US

Funding

TRANSPORT OF TRACE METALS IN A POLLUTED AQUIFERP42ES004940 · NIEHS · UNIVERSITY OF ARIZONA · PI Jon D Chorover · 1990 to 2026
$68.1M
SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
Alternaria proteases and protease defenses in asthmaR01AI083403 · NIAID · UNIVERSITY OF ARIZONA · PI DAINES, MICHAEL O · 2011 to 2015
$1.8M
PAR2 targeted drug discovery for the treatment of painR01NS073664 · NINDS · UNIVERSITY OF ARIZONA · PI BOITANO, SCOTT, PRICE, THEODORE J. · 2011 to 2015
$1.6M
NIAID NIH HHS R01 AI083403NIAID NIH HHS R01-AI-083403NIEHS NIH HHS ES-007091NIEHS NIH HHS ES-04940NIEHS NIH HHS P30 ES006694NINDS NIH HHS R01 NS073664NINDS NIH HHS R01-NS-073664
6 · The paper itself

Abstract

The airway epithelium provides a barrier that separates inhaled air and its various particulates from the underlying tissues. It provides key physiological functions in both sensing the environment and initiating appropriate innate immune defenses to protect the lung. Protease-activated receptor-2 (PAR2) is expressed both apically and basolaterally throughout the airway epithelium. One consequence of basolateral PAR2 activation is the rapid, Ca(2+)-dependent ion flux that favors secretion in the normally absorptive airway epithelium. However, roles for apically expressed PAR2 activation have not been demonstrated, in part due to the lack of specific, high-potency PAR2 ligands. In the present study, we used the newly developed PAR2 ligand 2at-LIGRLO(PEG3-Pam)-NH2 in combination with well-differentiated, primary cultured airway epithelial cells from wild-type and PAR2 (-/-) mice to examine the physiological role of PAR2 in the conducting airway after apical activation. Using digital imaging microscopy of intracellular Ca(2+) concentration changes, we verified ligand potency on PAR2 in primary cultured airway cells. Examination of airway epithelial tissue in an Ussing chamber showed that apical activation of PAR2 by 2at-LIGRLO(PEG3-Pam)-NH2 resulted in a transient decrease in transepithelial resistance that was due to increased apical ion efflux. We determined pharmacologically that this increase in ion conductance was through Ca(2+)-activated Cl(-) and large-conductance K(+) channels that were blocked with a Ca(2+)-activated Cl(-) channel inhibitor and clotrimazole, respectively. Stimulation of Cl(-) efflux via PAR2 activation at the airway epithelial surface can increase airway surface liquid that would aid in clearing the airway of noxious inhaled agents.

Indexed as

AnimalsAnti-Asthmatic AgentsCalcium SignalingCells, CulturedChloride ChannelsDrug Evaluation, PreclinicalEpithelial CellsIon Channel GatingMembrane PotentialsMice, Inbred C57BLOrnithinePalmitatesPotassium Channels, Calcium-ActivatedReceptor, PAR-2Respiratory MucosaTrachea2at-LIGRLO(PEG3-Pam)-NH2Anti-Asthmatic AgentsChloride ChannelsOrnithinePalmitatesPotassium Channels, Calcium-ActivatedReceptor, PAR-2allergic asthmaasthmagenion conductancelipidated agonistprotease-activated receptor-2

Identifiers

PMID25143347
PMCPMC4199996
OpenAlexW2325843162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.